In a retrospective cohort of patients with melanoma in situ (MIS) with non-lentigo maligna/non-acral lentiginous (non-LM/non-ALM) subtypes, no local recurrences, metastases, or melanoma-specific ...
Please provide your email address to receive an email when new articles are posted on . Positive margins are infrequent following standard excision, but when they do occur it is mostly in the upper ...
Melanoma in situ (MIS), also called stage 0 melanoma, is the earliest stage of melanoma, when the cancer is confined to the outermost layer of skin. Most melanomas affect the skin, but they can also ...
Mitotic rate ≥1/mm² and residual tumor presence are linked to higher relapse risk in cutaneous melanoma patients post-excision. Lymphovascular invasion significantly correlates with worse relapse-free ...
Stage 2 melanoma involves a significant tumor without lymph node or distant organ spread, determined by tumor thickness and ulceration. Treatment focuses on curative surgical excision, with adjuvant ...
A phase 1/2 study of vusolimogene oderparepvec (RP1) in primary melanoma (mel) to reduce the risk of sentinel lymph node (SLN) metastasis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
A midlands woman is sharing her experience of being diagnosed with skin cancer to highlight the importance of getting any concerning skin changes checked out by a GP.